Press

Op-eds and Articles

We can contain the spread of COVID-19 — but the federal government must step up before it’s too late

States and localities are proceeding with “opening” their economies despite the fact that most states have not met the re-opening criteria put forward by the White House. In order to head off spikes in cases, states and localities will need aggressive testing, contact tracing, and isolation programs. Testing is only as good as what you do with that…

People have increased anxiety and depression from Covid-19 — telehealth can help

Fears about the novel coronavirus, the economic meltdown, and prolonged self-isolation are taking an emotional toll on Americans. Calls to the federal mental health crisis hotline are 900 percent greater than this time last year. In normal times, one in five American adults deals with mental health issues. Anxiety is the most common mental disorder; 6.8 million people in the…

Paying the Bills for COVID-19: Three Ideas for Protecting Patients and America’s Health Care System

Covid-19 is hitting the United States harder than any other country in the world. Roughly 41,000 Americans have died from the novel coronavirus and more than 50,000 Americans have been hospitalized. Some experts estimate millions more could be hospitalized before the disease runs its course. Each Covid-19-related hospitalization costs between $30,000-$72,000 per person. However, it…

PPI in the News

Kane for The Hill: “Candidates should follow Sen. Harris’s lead on maternal health”

Senator and presidential candidate Kamala Harris (D-Calif.) reintroduced her 2018 bill that seeks to address rising maternal mortality rates, particularly among black women. Harris’s Maternal CARE Act, and the accompanying House version, would authorize $150 million toward programs that seek to help medical professionals identify high-risk pregnancies and establish implicit-bias training curriculum for medical schools. Her bill seeks…

Kane for The Hill, “Future of medicine could be tailored to your individual genetics if data gathered is meaningful”

In the future, medicine will be tailored to your individual “genome” or genetic code, lifestyle and community. Rather than a one-size-fits-most treatment, doctors will use data to determine what therapies you should receive based on genetic traits you’ve inherited from family, your daily habits, and where you live. But how do we get there? We…

MSNBC: What’s Bill Clinton up to on Obamacare?

MSNBC's Zachary Roth recently quoted Will Marshall, PPI President, on Clinton’s recent push to modify the Affordable Healthcare Act (ACA) in Congress.  Marshall was asked to interpret Clinton’s support for a legislative fix. “Not sure how helpful that was,” Will Marshall, the president of the Progressive Policy Institute, who worked closely with Clinton in the…

Press Releases

PPI Launches Series of New Ideas for a ‘Do-Something’ Congress

Dear Democratic Class of 2018, Congratulations on your election to the U.S. House of Representatives! In addition to winning your own race, you are part of something larger – the first wave of a progressive resurgence in U.S. politics. The midterm elections gave U.S. voters their first opportunity to react to the way Donald Trump…

Bledsoe for RCP: The Shared Illusions of Brexit and Obamacare Repeal

“Have your cake and eat it.”  With these six aggressively monosyllabic words, the redoubtable Boris Johnson came clean, almost despite himself, about the contradictions of Brexit, and perhaps those of today’s right-of-center populism altogether.  In time, the phrase may be seen as the defining utterance of the post-truth era in trans-Atlantic politics. The Washington corollary…

Press Release: PPI Releases Policy Memo Revealing FDA Regulations Struggling to Keep Up With the Digital Age

WASHINGTON—The amount of regulation on the pharmaceutical industry has increased 40 percent since 2000, according to a policy memo released today by the Progressive Policy Institute (PPI). Moreover, some new draft regulations proposed by the Food and Drug Administration (FDA) this year fail to embrace data-driven innovation. In FDA Regulation in the Data-Driven Economy, PPI…